Optimization of globomycin analogs as novel gram-negative antibiotics

Autor: Keira Garland, Richard Pastor, Gauri Deshmukh, Min Xu, Emily J. Hanan, Paul Gibbons, Yi-Chen Chen, Susan L. Gloor, Sharookh B. Kapadia, Homer Pantua, Sharada Labadie, Rongbao Hua, Yiming Xu, Marie-Gabrielle Braun, Yuhong Fu, Craig Stivala, Xiongcai Liu, Georgette Castanedo, Jonathan Cheong, Daniels Blake, Hao Zheng, Daniel J. Burdick, Yun-Xing Cheng
Rok vydání: 2020
Předmět:
Zdroj: Bioorganicmedicinal chemistry letters. 30(20)
ISSN: 1464-3405
Popis: Discovery of novel classes of Gram-negative antibiotics with activity against multi-drug resistant infections is a critical unmet need. As an essential member of the lipoprotein biosynthetic pathway, lipoprotein signal peptidase II (LspA) is an attractive target for antibacterial drug discovery, with the natural product inhibitor globomycin offering a modestly-active starting point. Informed by structure-based design, the globomycin depsipeptide was optimized to improve activity against E. coli. Backbone modifications, together with adjustment of physicochemical properties, afforded potent compounds with good in vivo pharmacokinetic profiles. Optimized compounds such as 51 (E. coli MIC 3.1 μM) and 61 (E. coli MIC 0.78 μM) demonstrate broad spectrum activity against gram-negative pathogens and may provide opportunities for future antibiotic discovery.
Databáze: OpenAIRE